Jane Doe p. +358 50 1234567 email: jane@xemet.com Xemet Co. Ltd. Science Park 1 FI-12345 Espoo Finland

1. Xemet Co. Ltd.
by
Dr. Tomi Heiskanen, CEO
at MoneyTalks Seminar
13th October 2011

2. Xemet develops and sells computing and
simulation services and software to Life Science
companies and research organizations.
The services and software reduce the cost, time
and risk of R&D.

3. The goal is to replace part of the experimental (in vitro & in
vivo) methods in Life Science R&D with Xemet’s computing
and simulation services and software (”in silico” methods)
in vitro & in vivo
in silico

4. The market opportunity:
“It
has been predicted that within the next few years up to 15% of drug
development budgets will be spent on modelling and simulation, with
the aim of saving significant time and money in drug development”
Pharmaceutical companies’ R&D spending is about 90 mrd €.
If 50% (45 mrd€) is “drug development” (probably more), then “modeling
and simulation” market is 15%*45 = 7 mrd € !
If Xemet’s market share is 5 %, it would correspond to 350 milj.€ !
…but, our customer industries include also
• Personal care and cosmetics (such as Procter&Gable, L’Oreal,…)
• Food and drink (such as Nestle, etc.)
• Chemical

5. …and this is not a fad !
for decades to come there will be continuous
increase in the customer need reinforced by legal
requiremenets such as REACH legislation in EU

6. Financial goals:
 Sales: 5 m€ in 2014 and 50 m€ in 2021
 Value of the company: 10 m€ in 3 years (2014) and
100 m€ in 10 years (2021)

7. TECHNOLOGY PLATFORM – THE MAIN ASSET AND IPR
SALES
Internal resources products, services
services
MATHEMATICAL MODELS OF
SIMULATION
BIOLOGICAL PHENOMENA
software
COMPUTATIONAL METHODS data/
DATABASES
databases
DATAMINING, MACHINE services
ALGORITHMS LEARNING, PATTERN
RECOGNITION software

8. THE TEAM
Dr. Tomi Heiskanen, CEO, founder of Xemet
Co.,specialized in mathematical modeling of complex
dynamical systems; 15 years as a private entrepreneur
(established, successfully developed and exited an other
high tech company during 1995-2007)
Prof.Timo Eirola, Advisor & consultant, professor of
mathematics at the Institute of Mathematics and the
Coordinator of the Program of Computational Science
and Engineering in Helsinki University of Technology.
Mr. Tomas Heiskanen, Manager, specialized in
information science, cognitive neuroscience,
bioinformatics, high performance computing,
proteomics and computational biology

9. CONTACT:
Tomi Heiskanen, CEO
p. +358 400 491568
email: tomi@xemet.com
www.xemet.com